figshare
Browse
12916_2016_572_MOESM1_ESM.docx (195.58 kB)

Additional file 1: Table S1. of Successful external validation of a model to predict other cause mortality in localized prostate cancer

Download (195.58 kB)
journal contribution
posted on 2016-02-09, 05:00 authored by Matthew Kent, David Penson, Peter Albertsen, Michael Goodman, Ann Hamilton, Janet Stanford, Antoinette Stroup, Behfar Ehdaie, Peter Scardino, Andrew Vickers
10- and 15-year prostate cancer mortality by age and risk group. Low risk, stage T1–T2, and Gleason score ≤6; intermediate risk, stage T1–T2, and Gleason score 7); high risk, stage ≥ T3 OR Gleason score ≥8. Table S2. Model inputs and outputs for some example patients. Risk of death from prostate cancer from the Swedish data; risk of death from other causes from the MALE model applied to US life tables; risk of death from prostate cancer, taking into account death from other causes. Figure S1. Life expectancy report. (DOCX 195 kb)

Funding

National Institutes of Health (US)

History